Market Place
Sourcing Support
Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr
23 Oct 2024 //
INDPHARMAPOST
Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
23 Jul 2024 //
INDIANPHARMAPOST
US FDA inspects Vishakhapatnam facility of Solara Active Pharma
20 May 2024 //
ECONOMICTIMES
This pharma company gets approval to set up a new MFGfacility drug `Ibuprofen`
01 Nov 2022 //
DSIJ
Solara Active Pharma slips 15% after Rajender Rao resigns as MD & CEO
02 May 2022 //
BUSINESS STANDARD
Solara Active Pharma Sciences announces change in MD and CEO
28 Feb 2022 //
BUSINESS-STANDARD
Solara Active Pharma hits fresh 52-week low, tumbles 35% in two session
11 Feb 2022 //
ECONOMIC TIMES
Solara Active Pharma gallops after Sequent Scientific buys stake
13 Jan 2022 //
BUSSINESS-STANDARD
Solara Active Pharma Sciences Limited on Health Canada Inspection List
08 Jan 2022 //
HEALTH CANADA
Greaves Cotton, Solara and Rajesh Exports shine on the first trading day of 2022
03 Jan 2022 //
BUSINESS-INSIER
Solara Active Pharma Sciences Ltd leads losers in `A` group
12 Nov 2021 //
BUSINESS-STANDARD
With EPS Growth And More, Solara Active Pharma Sciences Is Interesting
28 Oct 2021 //
SIMPLYWALL
Solara Active Pharma: Robust Growth Planned
25 Sep 2021 //
MONEYLIFE
Ex-HDFC Bank head Aditya Puri appointed chairman of Solara
04 Aug 2021 //
ECONOMICTIMES
Solara announces restoration of CEP for Ranitidine Hydrochloride
02 Jul 2021 //
BUSINESS-STANDARD
After rallying 6 times in 3 years, this API maker just got first ‘sell’ rating
20 May 2021 //
ECONOMICTIMES
Solara Active Pharma Shares Gain On Merger With Aurore Life Sciences
13 Apr 2021 //
BLOOMBERG
Solara & Aurore combine to create the second-largest Pure Play API company
11 Apr 2021 //
THEHANSINDIA
Board of Solara Active Pharma Sciences approves scheme of amalgamation
10 Apr 2021 //
BUSINESS-STANDARD
Solara Active Pharma board OKs amalgamation of Aurore, Empyrean
10 Apr 2021 //
BUSINESS-STANDARD
Outcome of board meeting of Solara Active Pharma Sciences
28 Feb 2021 //
BUSSINESS-STANDARD
Solara Active Pharma Sciences consolidated net profit rises 59.09% in the Dec
03 Feb 2021 //
BUSSINESS-STANDARD
Board of Solara Active Pharma approves acquisition of balance 10.77% stake
03 Feb 2021 //
BUSSINESS-STANDARD
Solara Active Pharma Sciences Is Growing Earnings But Are They A Good Guide?
11 Jan 2021 //
SIMPLYWALL
Solara Active Pharma Sciences Ltd board declares interim dividend of Rs. 4
10 Nov 2020 //
EQUITYBULLS
Solara Active Pharma surges 19% on heavy volumes, hits record high
06 Oct 2020 //
BUSINESS STANDARD
Solara Active Pharma Q1 net profit rises 60% to Rs. 42.28 crore
03 Aug 2020 //
PHARMABIZ
Board of Solara Active Pharma Sciences approves change in MD and CEO
03 Aug 2020 //
BUSINESS-STANDARD
Solara Active Pharma Sciences Ltd Surges 6.35%, S&P BSE Healthcare
29 May 2020 //
BUSINESS-STANDARD
Solara Active Pharma Sciences allots 8 lakh shares on conversion of warrants
26 May 2020 //
BUSINESS-STANDARD
R. Ramakrishnan Is The Independent Director of Solara Active Pharma Sciences
20 May 2020 //
SIMPLYWALL
How Does Solara Active Pharma Sciences’s P/E Compare To Its Industry
07 May 2020 //
SIMPLYWALL
Solara Active Pharma Sciences consolidated net profit declines 32.29%
07 May 2020 //
BUSINESS-STANDARD
Solara shares new updates on Ranitidine Hydrochloride API
02 Apr 2020 //
EQUITYBULLS
BRIEF-Solara Active Pharma Sciences Updates On Ranitidine Hydrochloride API
02 Apr 2020 //
REUTERS
The Solara Active Pharma Sciences Share Price Is Up 24% And Shareholders
28 Mar 2020 //
SIMPLYWALL
Solara Active Pharma Sciences allots 8 lakh shares on conversion of warrants
26 Mar 2020 //
BUSINESS-STANDARD
Sandesh Ltd leads gainers in `B` group
20 Mar 2020 //
BUSINESS-STANDARD
Analysts bullish on Solara Active Pharma share
07 Mar 2020 //
SUNDAYGUARDIANLIVE
Solara Puducherry And Mangalore Facilities Complete USFDA Inspection Zero 483s
24 Feb 2020 //
MEDICALDIALOGUES
USFDA inspections at Solara`s Puducherry & Mangalore with zero 483 observations
22 Feb 2020 //
EQUITYBULLS
Can We See Significant Insider Ownership On The Solara Active Pharma Sciences
10 Feb 2020 //
SIMPLYWALL
PE Funds Advent, Kedaara in discussions to acquire Sequent
15 Jan 2020 //
ECONOMIC TIMES
We Wouldn’t Rely On Solara Active Pharma Sciences’s Statutory Earnings
14 Jan 2020 //
SIMPLYWALL
US-based Mylan Pharma initiates voluntary recall of Nizatidine Solara Active
09 Jan 2020 //
THEHINDUBUSINESSLINE
Solara Active Pharma to conduct internal probe on Nizatidine API
08 Jan 2020 //
ECONOMIC TIMES
Solara Active Pharma Sciences Completes Yet another USFDA inspection Zero 483s
01 Jan 2020 //
UNIINDIA
Solara Active Pharma share price rises 3% on merger nod
24 Dec 2019 //
MONEYCONTROL
What To Know Before Buying Solara Active Pharma Sciences For Its Dividend
24 Dec 2019 //
SIMPLYWALL
Solara appoins Bharath R Sesha as new CEO
09 Dec 2019 //
ECONOMIC TIMES
Solara Active Pharma Sciences update on Ranitidine HCL & Nizatidine API
25 Nov 2019 //
BUSINESS-STANDARD
These 4 Measures Indicate That Solara Active Pharma Sciences
25 Nov 2019 //
SIMPLYWALL
Solara Active Pharma Sciences update on Ranitidine Hydrochloride & Nizatidine API
04 Nov 2019 //
BUSINESS-STANDARD
Read This Before Selling Solara Active Pharma Sciences Limited Shares
24 Oct 2019 //
YAHOO
Solara Active Pharma Sciences Ltd provides further updates on Ranitidine HCL API
23 Oct 2019 //
EQUITYBULLS
Solara Active Pharma Sciences Insiders Increased Their Holdings
03 Oct 2019 //
SIMPLYWALL
Solara Active Pharma slips after suspending ranitidine production
27 Sep 2019 //
BUSINESS-STANDARD
Solara Active Pharma slips after suspending ranitidine production
27 Sep 2019 //
BUSINESS-STANDARD
Do Solara Active Pharma Sciences’s (NSE:SOLARA) Earnings Warrant Your Attention?
26 Sep 2019 //
SIMPLYWALL
Sequent Scientific to acquire Solara Active Pharma Sciences` EU-GMP API at Mahad
22 Sep 2019 //
BUSINESS-STANDARD
